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a Department of Analytical Chemistry, Nutrition and Food Sciences, Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de 
Compostela, Constantino Candeira S/N, Santiago de Compostela 15782, Spain 
b Environmental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water, University Jaume I, Castellón, Spain 
c Department of Analytical Chemistry, Nutrition and Bromatology, Faculty of Chemical Sciences, University of Salamanca, Salamanca, Spain 
d FI-TRACE group, Department of Chemistry, University of the Balearic Islands, Palma de Mallorca, Spain 
e Asociación Ai Laket!! Elkartea, Vitoria-Gasteiz, Spain 
f Department of Analytical Chemistry, Faculty of Science and Technology, University of the Basque Country, Bilbao, Spain 
g Research Centre for Experimental Marine Biology and Biotechnology, University of the Basque Country (PiE-UPV/EHU), Plentzia, Basque Country 48620, Spain 
h Energy Control, Asociación Bienestar y Desarrollo, Barcelona, Spain   








A B S T R A C T   
Amphetamine (AMP), methamphetamine (MAMP) and 3,4-methylenedioxymethamphetamine (MDMA) occur in 
wastewater not only as a result of illicit consumption, but also, in some cases, from prescription drug use or by 
direct drug disposal into the sewage system. Enantiomeric profiling of these chiral drugs could give more insight 
into the origin of their occurrence. In this manuscript, a new analytical methodology for the enantiomeric 
analysis of amphetamine-like substances in wastewater has been developed. The method consists of a solid-phase 
extraction (SPE) followed by liquid chromatography-triple quadrupole-tandem mass spectrometry (LC-MS/MS), 
which showed low quantification limits in the 2.4–5.5 ng L− 1 range. The LC-MS/MS method was first applied to 
characterize a total of 38 solid street drug samples anonymously provided by consumers. The results of these 
analysis showed that AMP and MDMA trafficked into Spain are synthesized as racemate, while MAMP is 
exclusively produced as the S(+)-enantiomer. Then, the analytical method was employed to analyse urban 
wastewater samples collected from the wastewater treatment plants (WWTPs) of five different cities in 2018 and 
2019. Consumption estimated through normalized population loads in wastewater showed an increased pattern 
of AMP use in the Basque Country. Furthermore, the enantiomeric profiling of wastewater samples was con-
trasted to lisdexamfetamine (LIS) and selegiline (SEL) prescription figures, two pharmaceuticals which metab-
olize to S(+)-AMP, and to R(-)-AMP and R(-)-MAMP, respectively. From this analysis, and considering 
uncertainties derived from metabolism and adherence to treatment, it was concluded that LIS is a relevant source 
of AMP in those cases with low wastewater loads, i.e. up to a maximum of 60% of AMP detected in wastewater in 
some samples could originate from LIS prescription, while SEL does not represent a significant source of AMP nor 
MAMP. Finally, removal efficiencies could be evaluated for the WWTP (serving ca. 860,000 inhabitants) with 
higher AMP influent concentrations. The removal of AMP was satisfactory with rates higher than 99%, whereas 
MDMA showed an average removal of approximately 60%, accompanied by an enrichment of R(-)-MDMA.   
1. Introduction 
Amphetamine (AMP), methamphetamine (MAMP) and 3,4- 
methylendioxymethamphetamine (MDMA) are synthetic derivatives of 
phenylethylamine that were used in the past to treat narcolepsy and 
spastic states of the gastrointestinal tract (Myerson, 1939). However, 
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their stimulating effects have also been associated to a high risk of 
addiction (Guttmann and Sargant, 1942; Lemere 1967). Therefore, ac-
tions were taken to restrict their clandestine consumption. 
Besides classical population surveys, hospital-related admissions and 
other epidemiological indicators, efforts to detect illicit drugs’ use in a 
fast and non-invasive way led to the first study using wastewater-based 
epidemiology (WBE) in 2005 by Zuccato et al. (Zuccato et al., 2005). 
They estimated cocaine consumption in a specific population through 
the analysis of wastewater, as an complementary tool to the established 
epidemiological approaches. Nowadays, this methodology has been 
applied in many countries to get a near real-time profiling of the 
community-wide use of illicit drugs (Bijlsma et al., 2021; 
González-Mariño et al., 2020; Ort et al., 2014; Thomas et al., 2012), 
alcohol and tobacco (Castiglioni et al., 2015; Gao et al., 2020; 
López-García et al., 2020; Montes et al., 2020; Rodríguez-Álvarez et al., 
2015, 2014a, 2014b; Ryu et al., 2016; Tscharke et al., 2016). Addi-
tionally, WBE has been extended to estimate (unwanted) exposure to 
chemicals (Senta et al., 2020), such as pesticides (Rousis et al., 2016), 
flame retardants (Been et al., 2018; Castro et al., 2020), bisphenol A 
(Lopardo et al., 2019) and plasticizers (Estévez-Danta et al., 2021; 
González-Mariño et al., 2021, 2017), and more recently as a useful tool 
to follow and predict the evolution of COVID-19 (Ahmed et al., 2020; 
Alygizakis et al., 2020; Medema et al., 2020). 
A key factor in WBE studies is the selection of appropriate human 
biomarkers. However, the estimation of AMP, MAMP and MDMA con-
sumption is sometimes troublesome, because the biomarkers usually 
measured in wastewater are the parent compounds (i.e. unchanged 
excreted fraction), which can occur in wastewater not only as a result of 
illicit consumption, but also from prescription drug use or direct disposal 
from waste of illegal drug production (Emke et al., 2014). Yet, these 
three drugs are chiral and contain one asymmetric carbon atom that 
leads to two enantiomers (R-(-) and S-(+)). In the human body, this 
chirality implies different biological activity, and consequently, 
different distribution and metabolism (Kalant 2001; Kasprzyk-Hordern 
et al., 2010). 
Illicit AMP and MDMA are usually synthetized by the Leuckart 
method to yield a racemic mixture (EMCDDA, 2021a, b; Emke et al., 
2018; Hauser et al., 2020; Kalant 2001; King 2009), whereas MAMP is 
mainly produced as pure S-enantiomer across Europe, with the only 
reported exception of Norway, where the synthesis facilities are 
different than in Central Europe, and usually synthetize MAMP as a 
racemate (Castrignanò et al., 2018). AMP and MAMP are used in some 
countries as a prescribed medication to treat attention deficit/-
hyperactivity disorder (ADHD), narcolepsy, or as a dietary supplement 
to lose weight (Cody, 2002). In Spain, AMP is not prescribed itself, but as 
the prodrug lisdexamfetamine (LIS, used to treat ADHD), which is 
metabolized to S-(+)-AMP in the human body (Comiran et al., 2021; 
Krishnan et al., 2008; Pennick, 2013). MAMP and MDMA do not 
currently have medical applications. However, selegiline (SEL), a 
medication used in Parkinson treatment, metabolizes to produce the R 
(-)-enantiomer of AMP and MAMP (Reynolds et al., 1978). Thus, both 
LIS and SEL could be potential sources of AMP and MAMP in sewage, 
besides illicit consumption (Castrignanò et al., 2018; Lertxundi et al., 
2021). 
In the case of these three amphetamine-like substances, the S 
(+)-enantiomer is more active and therefore metabolizes faster than the 
R(-)-enantiomer (Kasprzyk-Hordern, 2010; Kasprzyk-Hordern and 
Baker, 2012). This, consequently, results in a change of the enantiomeric 
ratio towards the enrichment of the R(-)-enantiomer. Thus, mainly the 
R-enantiomer is detected in untreated wastewater if the racemic drug is 
consumed. Hence, enantiomeric analyses can complement traditional 
WBE estimates by applying analytical methods that allow the determi-
nation of different chiral drug enantiomers, and therefore differentiate 
between licit (prescription) or illicit use, or direct dumping in the 
sewage network (Castrignanò et al., 2018; Emke et al., 2014; Gao et al., 
2018). 
Enantiomeric profiling has been mainly performed by liquid chro-
matography coupled to tandem mass spectrometry (LC-MS/MS) in 
combination with a previous sample concentration (usually a solid- 
phase extraction (SPE)). Kaspryzk-Horden and Baker (Kasprzy-
k-Hordern and Baker, 2012) were the first to address chiral analysis of 
these substances. In that first study, Oasis MCX cartridges were used for 
SPE, due to the basic nature of the illicit drugs studied. However, Oasis 
HLB cartridges have also been employed in some other studies (Archer 
et al., 2018; Castrignanò et al., 2016; Vazquez-Roig et al., 2014). 
Although there are some WBE-derived studies targeting enantio-
meric separation in different countries (Archer et al., 2018; Castrignanò 
et al., 2018; Emke et al., 2014; Gao et al., 2018; Kasprzyk-Hordern and 
Baker, 2012), in Spain, enantiomeric profiling has been applied only to 
two cities (Castellón and Valencia) of the Valencian Community region 
(Castrignanò et al., 2018; Vazquez-Roig et al., 2014). Moreover, in a 
more recent study on WBE of illicit drugs in Spain (Bijlsma et al., 2021) 
high levels of AMP were observed in the area of Bilbao. However, the 
origin of such substance could not be fully clarified (Lertxundi et al., 
2021), even when a preliminary version of the enantiomeric profiling 
method presented here was used. Hence, the aim of this work was to 
delve into spatial differences by including 5 mid-to-large cities (and 
their metropolitan areas), located in five Spanish regions and covering 
around 2 million people overall. To that end, we have developed and 
validated a new enantiomeric analysis method and applied it to AMP, 
MAMP and MDMA street drug samples obtained from different locations 
in Spain to evaluate their enantiomeric fractions and purity. Also, 
wastewater samples from the above-mentioned regions were collected 
in 2018 and 2019 and analysed. Finally, a detailed discussion on the 
contribution of the prescription drugs LIS and SEL to the amounts of 
AMP and MAMP detected in wastewater is presented for the first time. 
2. Material and methods 
2.1. Chemicals and reagents 
Individual solutions of 1 mg mL− 1 of AMP, MAMP and MDMA, and of 
0.1 mg mL− 1 of their deuterated analogues (AMP-D6, MAMP-D5 and 
MDMA-D5, used as internal standards (ISs)), were supplied by Cerilliant 
(Round Rock, TX, USA) as racemic mixtures. Individual solutions of 1 
mg mL− 1 of the S-(+) enantiomer of AMP, MAMP and MDMA were 
supplied by Merck (Darmstadt, Germany). 
Ultrapure water was obtained with a Millipore Milli-Q Gradient A-10 
system (Bedford, MA, USA). LC-MS grade methanol (MeOH), formic acid 
(95–97%), ammonium bicarbonate (≥ 99.5%) and ammonia (NH3) so-
lution in water (25%) were supplied by Merck. Ammonia solution in 
MeOH (7 N) was supplied by Across Organics (Thermo Fischer Scienti-
fic, Geel, Belgium). 
2.2. Drug dose samples 
Street drug samples were supplied by Energy Control and Ai Laket!! 
as powder or crystal. These two Spanish Organizations aim to reduce 
risks related to recreational drug use by providing fast and anonymous 
information to users on the composition of the drugs they are going to 
consume. Hence, such drugs were submitted to the harm-reduction, 
drug-checking services in an anonymous way and were then shipped 
to Santiago de Compostela for analysis. These drug samples were diluted 
to a nominal concentration of 250 ng mL− 1 of powder in MeOH, spiked 
with the ISs (100 ng mL− 1 each) of and injected into the LC-MS/MS 
system. 
2.3. Wastewater samples 
Composite 24 h raw wastewater samples were collected at five 
wastewater treatment plants (WWTPs) located in Spain for 7 consecu-
tive days in Spring 2018 and 2019, except in the WWTP of Palma for 
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which samples were only collected in 2018. Details on each location, 
population served by each WWTP, and sampling are displayed in 
Table S1. 
In addition, in 2019, treated wastewater samples from the WWTP of 
Galindo (Bilbao and its large metropolitan area), in which high con-
centrations of AMP were detected, were collected with a delay of 24 h 
with respect to raw wastewater (June 12th-18th) in order to assess 
(enantioselective-)removal efficiencies, on request of the WWTP man-
agers. This WWTP treats the wastewater from over 850,000 inhabitants, 
with an average flow of ca. 250,000 m3 day− 1 (Table S1). The WWTP is 
equipped with a primary treatment (flocculation and coagulation) and a 
secondary conventional activated sludge treatment, including anoxic/ 
anaerobic and aerobic treatments. The average hydraulic and sludge 
retention times are 24 h and 22.5 days, respectively. 
2.4. Wastewater samples pretreatment 
Sample preparation was performed by two different analytical 
methods to identify and quantify chiral drugs in wastewater. 
2.4.1. Method A 
All samples, except those from Castellón and Madrid (see 2.4.2) were 
processed in Santiago de Compostela with method A, following the 
protocol described by González-Mariño et al. (2018) with some modi-
fications (see discussion on 3.2). Briefly, 100 mL of samples were 
vacuum-filtered through 0.7 µm GF/A glass microfiber filters (What-
man, Kent, UK) and 0.45 µm cellulose acetate filters (Millipore) and 
spiked with the ISs (100 ng L− 1 each). SPE was performed by 
mixed-mode reversed-phase strong cation-exchange cartridges (Oasis 
MCX-150 mg, Waters, Milford, MA, USA) previously rinsed with 5 mL of 
5% NH3 in MeOH followed by 5 mL of ultrapure water. After loading, 
sorbents were dried under a nitrogen stream during 30 min, washed 
with 4 mL of MeOH as a clean-up solution, and analytes were then eluted 
with 3 mL of 5% NH3 in MeOH. Eluates were evaporated to dryness 
under a nitrogen stream using a Turbo-Vap II (Zymark, Hopkinton MA, 
USA) and a Mini-Vap (Supelco, Steinheim, Germany) concentrators. 
Finally, extracts were redissolved in 100 µL of MeOH, filtered through 
0.22 µm PVDF syringe-driven filters (Merck) and injected into the LC-MS 
system. 
2.4.2. Method B 
Samples from Castellón and Madrid were extracted in the laboratory 
of the University Jaume I, following the protocol described by Bijlsma 
et al. (2014a), hereinafter, method B. In brief, 25 mL of sample were 
four-times diluted with ultrapure water, spiked with 1 ng mL− 1 of ISs 
mixture and filtered through 0.45 µm cellulose filters (Millipore). Then, 
SPE was performed by Oasis HLB-60 mg reversed-phase cartridges 
(Waters) previously rinsed with 4 mL of MeOH followed by 4 mL of 
ultrapure water. After loading, sorbents were dried under a nitrogen 
stream during 30 min and analytes eluted with 5 mL of MeOH. Eluates 
were evaporated to dryness under nitrogen using a Turbo-Vap II and a 
Mini-Vap concentrators. Finally, extracts were redissolved in 1 mL of 
10% MeOH in ultrapure water. These extracts were shipped frozen to 
Santiago de Compostela, where they were evaporated to dryness, 
redissolved in 100 µL of MeOH and filtered through 0.22 µm PVDF 
syringe-driven filters, being then ready for LC-MS/MS analysis. 
2.5. Instrumental analysis 
Instrumental analysis was performed with a Waters Acquity UPLC® 
H-class system equipped with a quaternary solvent pump, a thermo-
stated LC column compartment, and a sample manager. The UPLC sys-
tem was interfaced to a triple quadrupole mass spectrometer Xevo TQD 
from Waters. 
The chromatographic separation was performed at 40 ◦C on a Lux 
AMP chiral column (150 × 3 mm I.D., 3 µm particle size) from 
Phenomenex (Torrance, CA, USA). Under final working conditions, a 
dual eluent system consisting of (A) ultrapure water with 50 mM NH3 
and (B) MeOH was used at a flow rate of 0.4 mL min− 1. The linear 
gradient consisted of the following stages: 0 min (60% B), 15 min (60% 
B), 20 min (95% B), 25 min (95% B), 25.1 min (60% B) and 30 min (60% 
B). Injection volume was set at 10 µL. 
The interface between the UPLC system and the Xevo TQD mass 
spectrometer was an electrospray ionization (ESI) source operating in 
positive mode at a fixed capillary voltage of 3 kV and a temperature of 
150 ◦C. Nitrogen, provided by a nitrogen generator from Peak Scientific 
(Barcelona, Spain), was used as desolvation gas at 600 L h− 1 and 450 ◦C, 
and as cone gas at 10 L h− 1. Analyses were performed by MS/MS in 
Selected Reaction Monitoring (SRM) mode acquiring one precursor/ 
product ion transitions per IS and two transitions per analyte (one of 
them used for quantification and the second one for confirmatory pur-
poses). Argon was used as collision gas. Table S2 compiles chemical 
formulae, retention times (RT), transitions (Q) and optimal cone volt-
ages (CV) and collision energies (CE) for every analyte. 
2.6. Method performance and quality assurance 
Instrumental detection and quantification limits (IDLs and IQLs) 
were estimated from the lowest concentration level of the calibration 
curve providing a signal-to-noise ratio (S/N) of 3 and 10, respectively. 
Calibration curves were prepared in MeOH and ranged from the IQL to 
2500 ng mL− 1 for AMP enantiomers and from the IQL to 500 ng mL− 1 for 
the enantiomers of the remaining compounds (spiked IS concentration, 
referred to the final extract and each enantiomer: 100 ng mL− 1 for 
method A and 10 ng mL− 1 for method B). Intra-day and inter-day 
instrumental precision were assessed by the relative standard devia-
tion (RSD%) of seven injections of two calibration standards, containing 
5 ng mL− 1 and 50 ng mL− 1 of all analytes and 100 ng mL− 1 of IS. In-
jections were performed within the same day (intra-day precision) and 
in four different days within a month (inter-day precision). 
Trueness and precision of the whole SPE-LC-MS/MS method A were 
assessed by recovery studies in ultrapure water and wastewater spiked 
with 12.5 ng L− 1 and 125 ng L− 1, respectively, of all the analytes (100 ng 
L− 1 of IS). Wastewater aliquots spiked only with ISs were also analysed 
to account for analyte levels in this matrix. Matrix effects (MEs) were 
calculated as the signal (analyte peak area) percentage in a 125 ng mL− 1 
spiked wastewater extract, after non-spiked sample signal subtraction 
and referred to the signal of a 125 ng mL− 1 standard. Method detection 
limits (MDLs) and method quantification limits (MQLs) were calculated 
from non-spiked wastewater samples for a signal-to-noise ratio (S/N) of 
3 and 10, respectively. 
In the case of method B, quality of data was assured by analysing 
additional extracts provided by the University Jaume I, which had been 
previously already analysed in such University and were used as quality 
controls (QC). Thus, four samples of wastewater samples were spiked at 
two concentration levels (two of them with 50 ng L− 1 and the remaining 
two with 400 ng L− 1, referring to each enantiomer) were extracted at the 
University Jaume I, following sample pretreatment method B. The 
resulting extracts were shipped to the University of Santiago de Com-
postela, where they were analysed to assess method’s trueness and 
precision, and to calculate the MDLs and MQLs (extrapolated from the 
lowest level spiked sample). 
2.7. Calculations of enantiomeric fractions 
The elution order of enantiomers was confirmed by the analysis of S 
(+)-enantiomerically pure standards. The concentration of each enan-
tiomer was calculated by the internal standard calibration method. 
Then, the concentration of each enantiomer (CR for the R(-)-enantiomer 
and CS for S(+)-enantiomer) was used to obtain the enantiomeric frac-
tion (EF). In this work, EF is presented as EFR, i.e. the ratio between the 
concentrations of the R(-)-enantiomer and the sum of both enantiomers, 
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2.8. Estimation of human illicit drugs consumption 
Drug concentration (sum of both enantiomers) in 24 h composite 
influent samples were used to estimate population-normalized daily 
load levels (Eq. (2)) of each drug and, eventually, consumption (Eq. (3)): 
Daily loads =
Concentration × Flow rate
Population
× 1000 (2)  
Consumption = Daily loads × CF (3) 
The correction factor (CF) values, which consider the fraction of drug 
excreted after human metabolism, were: 2.77 (AMP), 2.3 (MAMP), and 
4.4 (MDMA), as proposed in (Gracia-Lor et al., 2016). 
3. Results and discussion 
3.1. Liquid chromatography-tandem mass spectrometry 
Separation was performed on a Lux AMP column. A dual eluent 
system consisting of (A) ultrapure water and (B) MeOH was used, with 
the addition of three different modifiers to the aqueous phase: 5 mM of 
ammonium bicarbonate at pH 11 (recommended by the column sup-
plier), 50 mM of NH3 at pH 11, and 5 mM of ammonium acetate at pH 9. 
An adequate separation of enantiomers was observed at pH 11, inde-
pendently of the modifier used (ammonium bicarbonate and NH3). 
Conversely, ammonium acetate at pH 9 could not resolve the chro-
matographic peaks of the enantiomers, likely due to the incomplete 
neutralization of the target species at this pH (Fig. S1). Finally, 50 mM of 
NH3 at pH 11 was selected as aqueous mobile phase additive due to the 
higher signal intensity and lower noise observed as compared to the 
addition of ammonium bicarbonate (Fig. S1). 
Instrumental parameters investigated include linearity, IDLs, IQLs, 
and intra- and inter-day precision (Table 1). The representation of the 
analyte area/IS area (response) versus spiked analyte concentration 
(IQL-2500 ng mL− 1 range for each AMP enantiomer and IQL-500 ng 
mL− 1 range for the remaining enantiomers) fitted a linear model with 
determination coefficients (R2) higher than 0.997. IDL and IQL values 
varied between 0.2 ng mL− 1 and 0.4 ng mL− 1, and between 0.6 ng mL− 1 
and 1.4 ng mL− 1, respectively. RSD values from the intra-day precision 
varied between 0.7% and 4.3% for the 5 ng mL− 1 standard and between 
0.5% and 3.3% for the 50 ng mL− 1 level. RSD from the inter-day pre-
cision was < 8.6% at 50 ng mL− 1, and < 4.8% at 5 ng mL− 1 except for S 
(+)-MAMP, for which it was 12%. 
3.2. Solid-phase extraction 
The extraction protocol applied in method A was based on a previous 
study (González-Mariño et al., 2018) but modified in order to improve 
its selectivity, by including a clean-up step, and optimizing the elution 
solvent volume. First, absolute recoveries for samples extracted with 
Oasis MCX (125 ng L− 1 spike level) were compared to the sample 
preparation recoveries obtained when introducing a clean-up step with 
4 mL of MeOH before the elution (performed with 5% NH3 in MeOH in 
both cases) (Fig. S2a). Both protocols showed good and comparable 
recoveries; thus, no significant losses were observed due to the clean-up. 
Also, MEs were tested for both protocols, since previous studies had 
reported improvements in this regard after the introduction of a 
clean-up step (González-Mariño et al., 2012, 2009; Senta et al., 2013). 
Significantly lower matrix effects were observed (i.e. values of %ME 
close to 100%) when the clean-up step was included (Fig. S2b). Finally, 
the elution volume was optimized by collecting three consecutive frac-
tions of 3 mL of 5% NH3 in MeOH, which were analysed independently. 
More than 94% of all analytes eluted in the first fraction (data not 
shown), and, consequently, the elution volume was reduced from 10 mL 
in the former method (González-Mariño et al., 2018), to only 3 mL. 
3.3. Method performance 
Method A was validated in terms of trueness, precision, MDLs and 
MQLs (Table 1). Percentages of recovery (%R) for triplicate analyses of 
ultrapure water samples, spiked with 12.5 ng L− 1 of all analytes and 100 
ng L− 1 of IS, varied between 90% and 105%, with RSDs between 1% and 
6%. In raw wastewater samples spiked with 125 ng L− 1 of all enantio-
mers and 100 ng L− 1 of IS,%R varied between 82% and 116%, and RSD 
between 4% and 15%. MDLs ranged from 0.7 ng L− 1 to 1.8 ng L− 1, and 
MQLs from 2.4 ng L− 1 to 5.5 ng L− 1. Table S3 compares the performance 
of the proposed method versus other analytical methods developed for 
the determination of chiral amphetamine-like substances in raw 
wastewater. IQLs and MQLs were at the same order of magnitude than 
those reported in other methodologies (Archer et al., 2018; Castrignanò 
et al., 2016, Castrignanò et al., 2018; Gao et al., 2018; Kasprzy-
k-Hordern et al., 2010). However, all those methods rely on the appli-
cation of reversed-phase Oasis HLB cartridges, which can perform well 
in terms of trueness (see also below), but do not offer the same degree of 
selectivity as obtained by mixed-mode SPE. A further advantage of the 
method proposed here is that the chromatographic separation is per-
formed under gradient conditions, which increases column lifetime 
when a complex matrix, as is the case of wastewater, is analysed. Finally, 
the run time of the chromatographic method developed here is 30 min, 
considerably lower than over 140 min required for other chiral sepa-
rations (Kasprzyk-Hordern, 2010; Vazquez-Roig et al., 2014). 
Since the samples from Castellón and Madrid had already been 
extracted by another SPE protocol based on Oasis HLB cartridges 
Table 1 
Instrumental validation and method performance.  
Compound R2 a Instrumental precision IDL b IQL c Trueness and Precision 
%R (RSD) 
MDL b MQL c  
Intra-day (%RSD, n = 7) Inter-day (%RSD, n = 7) ng mL− 1 ng mL− 1 Ultrapure water d Wastewater e ng L− 1 ng L− 1 
5 ng mL− 1 50 ng mL− 1 5 ng mL− 1 50 ng mL− 1 
R(-)- AMP 0.9991 2.1 1.5 3.8 5.4 0.3 0.8 95 (6) 95 (6) 1.8 5.5 
S(+)- AMP 0.9995 4.3 3.3 3.3 8.5 0.4 1.0 90 (6) 100 (7) 1.7 5.1 
R(-)- MAMP 0.9972 2.9 1.2 4.8 2.1 0.4 1.4 99 (3) 82 (15) 0.7 2.4 
S(+)- MAMP 0.9988 1.2 1.8 12 8.6 0.3 1.0 105 (1) 94 (9) 0.7 2.4 
R(-)- MDMA 0.9999 1.1 1.1 2.8 2.8 0.2 0.6 100 (5) 116 (4) 1.5 4.9 
S(+)- MDMA 0.9990 0.72 0.51 0.92 1.2 0.2 0.6 100 (3) 111 (4) 1.4 3.5  
a IQL-500 ng mL− 1, except AMP enantiomers: IQL-2500 ng mL− 1. 
b Calculated for a S/N = 3 for the qualifier transition. 
c Calculated for a S/N = 10 for the quantifier transition and S/N ≥ 3 for the qualifier transition. 
d Samples spiked with 12.5 ng L− 1 of each enantiomer, n = 4. 
e Samples spiked with 125 ng L− 1 of each enantiomer, n = 4. 
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(method B) and the enrichment increased by further evaporation of the 
extracts (see 2.4.2), the performance of this protocol was evaluated 
through recovery studies with the QC samples. As it is displayed in 
Table S4, recoveries varied between 66% and 125% and RSD < 17%; 
thus, this SPE protocol was acceptable in terms of trueness and preci-
sion. MQL values, estimated from the lowest concentration QC samples, 
ranged from 3.8 to 8.3 ng L− 1. 
3.4. Drug samples characterization 
Sample code, main drug, origin, purity and EFR of each drug sample 
herein analysed are listed in Table S5. The 38 drug dose samples were 
submitted to the two drug-checking services (Energy Control and Ai 
Laket!!) by anonymous drug consumers. Consumers labelled them as the 
drugs they expected them to contain: 18 were labelled as AMP, 6 as 
MAMP, and 14 as MDMA. Sample purity (evaluated as explained in 2.2) 
is summarized in Table 2 (details in Table S5). AMP samples presented a 
variable purity ranging from 2.7% to 103%. MAMP purity was more 
consistent and ranged between 54% and 76%, while MDMA purity 
varied between 0% and 107%. No MDMA was found in the sample coded 
MDMA-4, collected in Andalucía (Table S5). The results as regards EFR 
show a concordance with the reported synthesis route of these drugs in 
Europe (Castrignanò et al., 2018; King 2009). Thus, AMP and MDMA 
samples were all racemate mixtures, while MAMP samples were all the 
pure S(+)-enantiomer (Table 2 summarizes also the results shown in 
Table S5). The limited number of samples does not allow us to address 
regional patterns. 
3.5. Wastewater analysis 
EFR of the amphetamine-like substances found in wastewater were 
calculated from the concentrations measured in this matrix (see Eq. (1)). 
Following WBE calculations, loads (Eq. (2)) and human consumption 
(Eq. (3)) were subsequently estimated. The total concentration (sum of 
the two enantiomers) measured is summarized in Table 3 (detailed re-
sults are provided in Table S6). Excretion loads and estimated con-
sumption values per city, substance and year are summarized in Table 3 
(further details in Tables S7 and S8). Weekend peaks in loads/con-
sumption (Tables S7 and S8) were observed in most locations for MDMA, 
while this was not so clear in the case of AMP or MAMP. A potential 
explanation is that these two last substances may originate either from 
daily abusers or prescription patients, particularly in the case of AMP, as 
further discussed below. Similar results have been observed in several 
other countries (Castrignanò et al., 2018; Thomas et al., 2012). 
3.5.1. Amphetamine 
AMP was positively detected in all the wastewater samples. The high 
concentration levels found in Bilbao and its metropolitan area in 2018 
(mean 663 ng L− 1) (Bijlsma et al., 2021) were confirmed in 2019 (mean: 
1375 ng L− 1) (Table 3). Although considerably lower, the second highest 
concentrations were detected in Palma (mean values: 106 ng L− 1, only 
samples from 2018 available). The highest loads were observed in Bilbao 
in 2019 (mean 277 mg day− 1 1000 inhabitant− 1), even higher than the 
loads reported in 2018 (mean 203 mg day− 1 1000 inhabitant− 1). In the 
remaining cities, the estimated loads of AMP was lower than 45 mg 
day− 1 1000 inhabitant− 1 (Table 3). These results match former 
observations in Spain and confirms the distinct pattern of consumption 
in the area of Bilbao, which is closer to the patterns observed in other 
countries such as Belgium, Western Germany (Been et al., 2016) or some 
Nordic countries, where AMP is one of the most prevalent drugs 
(González-Mariño et al., 2020). 
The enantiomeric analysis showed a slight enrichment of R(-)-AMP 
in the wastewater of most cities, with EFR higher than 0.5 (Table 3, 
details in Table S9). This matches the data obtained from the analysis of 
urine of 165 abusers with provided and average EFR of 0.508 (George 
and Braithwaite, 2000) and highlights the fact that enrichment of R 
(-)-AMP (due to faster metabolization of S(+)-AMP) in the human body 
is not as high as in the case of MDMA (see 3.5.3), therefore making it 
difficult to differentiate illicit consumption from dumping events (that 
would lead to racemic AMP) on the basis of enantiomeric analysis only, 
as described by Emke et al. (2014). Despites this fact, dumping it is 
unlikely to play a major role in our study since, even in the case of 
Bilbao, where very high loads would point to direct disposal, no 
abnormal lead peak was detected on any singular day and associated to a 
change in the value of EFR (Tables S6–S9), as already observed, for 
instance, for AMP and MDMA dumping events in The Netherlands 
(Emke et al., 2014). 
Yet, the EFR obtained here are similar to those reported in other cities 
across Europe (Castrignanò et al., 2018), including Valencia (Vaz-
quez-Roig et al., 2014). In the case of Castellón, the EFR laid between 
0.49±0.03 and 0.50±0.02 (Table 3), which is equivalent to a racemic 
mixture. Samples from Castellón were also measured in 2015 by 
Castrignanò et al. (Castrignanò et al., 2018), yet AMP was not detected 
that study. Conversely, an enrichment of S(+)-AMP was detected in 
Madrid (Northern area) in 2018 with an average EFR of 0.41±0.03, 
while only the S(+) isomer was detected above the MQL in 2019 
(Table 3). Such observation could be partly related to a high contribu-
tion of LIS prescription in that area. In order to evaluate the potential 
contribution of medical prescription of LIS to WBE-derived consumption 
estimations, these data were compared with the available LIS prescrip-
tion data from four of the five studied regions (Galicia, Basque Country, 
Balearic Islands and Community of Madrid; data from the Community of 
Valencia was not available). These data (as defined daily doses (DDD) 
day− 11,000 inhabitants− 1) were obtained on a month basis for the 
province or municipality (see details in Table S10). Prescription data 
were converted into excretion loads of AMP, considering the DDD of LIS 
(30 mg, https://www.whocc.no/atc_ddd_index/), the average excretion 
of S(+)-AMP from LIS (44.75%), and the molecular weights of both 
drugs. The excretion value of 44.75% was derived as the average from 
two studies, performed with 7 individuals each, where S(+)-AMP 
accounted for 48.5% and 41% of the LIS dose, respectively (Comiran 
et al., 2021; Krishnan et al., 2008) (Table S11). 
As it is displayed in Table 4, the expected loads of S(+)-AMP from LIS 
prescription range from 1.0 to 7.0 mg day− 1 1000 inhabitant− 1. When 
compared to the loads of AMP (sum of both enantiomers) actually found 
in wastewater, the prescription of LIS would account for less than 1% of 
the AMP consumption estimated in Bilbao and its metropolitan area, 
clearly pointing to illicit drug use. Conversely, in Madrid (Northern 
area) about 58% of AMP consumption in 2018 could be explained by 
prescription, which, together with EFR results (< 0.50 in 2018, R 
(+)-AMP below MQL in 2019) could confirm a mixed origin (illicit use 
and LIS prescription). In Santiago de Compostela, medical prescription 
contribution is expected to be relatively high (over 37–44%, Table 4), 
but the EFR was above 0.53 (Table S9) in all samples, which could then 
indicate that illicit consumption would be more relevant than LIS pre-
scription. This disagreement may be explained by the fact that the 
external psychology consultations at the Santiago’s hospital cover a 
larger healthcare area, thus, many of the patients do not live in this area 
and thus do no contribute to the wastewater samples. Further factors 
contributing to the uncertainty of the estimations made are non- 
adherence to prescription, which has been calculated to be a 30% in 
Spain (Siffel et al., 2020). Therefore, data presented in Table 4 would 
Table 2 
Summary of the results obtained from the analysis of drug samples.  
Drug N EFR Mean ± SD Purity (%) 
Mean Median SD Range 
AMP 18 0.506 ± 0.006 41 39 29 2.7–103 
MAMP 6 0 65 63 7 54–76 
MDMA 14 0.505 ± 0.006 70 55 33 0–107 
N: number of samples. 
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likely represent an overestimating scenario (maximum contribution of 
prescription) and the real contribution of LIS would be lower. Even with 
these data in mind some EFR values would be higher than 0.5 in loca-
tions where prescription should be a relevant source. This is further 
limited by the fact that when pure (George and Braithwaite, 2000) or 
enriched enantiomer (Cody et al., 2003) medications are prescribed, a 
certain degree of interconversion occurs over time, which would lead to 
excretion of some R(-)-AMP and not only pure S(+)-AMP. 
Considering these limitations, it seems still evident that the contri-
bution of LIS prescription should be taken into account in future studies, 
particularly in those areas where the amount of AMP measured in 
wastewater is rather low. 
As regards the contribution of SEL prescription to R(-)-AMP in 
wastewater, the expectable loads would range from 0.0028 to 0.022 mg 
day− 1 1000 inhabitant− 1 (Table S12). Those data were obtained from 
SEL prescription figures, considering a 15.4% excretion rate, as the 
weighted average of 4 different studies with a total of 21 individuals 
(detailed in Table S13) (Elsworth et al., 1978; Heinonen et al., 1989; 
Liebowitz et al., 1985; Reynolds et al., 1978) and the corresponding 
molecular weights. Such loads can be considered as negligible as they 
are two orders of magnitude lower than those from LIS, therefore rep-
resenting less than 0.2% of the total AMP in any of the WWTPs. Actually, 
even in Palma, where the prescription of SEL was higher and with a dry 
precipitation regime (thus lower WWTP inflows) such loads will trans-
late into ca. 0.2 ng L− 1 concentrations of R(-)-AMP, i.e. below the MDL of 
the method. 
3.5.2. Methamphetamine 
Only S(+)-MAMP was detected in wastewater and the concentrations 
were low in all cities, with average values below 45 ng L− 1 (Table 3) and 
maximum values up to 54 ng L− 1 (Table S6). S(+)-MAMP average loads 
were lower than 13 mg day− 1 1000 inhabitants− 1 (Tables 3 and S7), 
confirming previous observations in Spain, with Barcelona, not analysed 
here, being the exception (Bijlsma et al., 2021; González-Mariño et al., 
2020). 
The prescription of SEL would be equivalent to loads in the 
0.0090–0.072 mg day− 1 1000 inhabitant− 1 (Table S12), after consid-
ering an average excretion of R(-)-MAMP of 45.5% from SEL, according 
to the metabolism data compiled in Table S13 (Elsworth et al., 1978; 
Heinonen et al., 1989; Liebowitz et al., 1985; Reynolds et al., 1978). 
Again, as in the case of AMP, considering Palma as the place where the 
highest contribution of SEL prescription towards R(-)-MAMP is ex-
pected, this would result into concentrations of ca. 0.6 ng L− 1, which is 
below the MDL. 
Thus, as regards the enantiomeric profiling of MAMP, EFR was al-
ways 0, i.e. R(-)-MAMP was below MDL in all samples (Table S9). These 
data reinforces the results observed in 3.4 that indicated that MAMP 
consumed in Spain is synthesized as pure S(+)-MAMP, as in most parts 
of Europe, while the contribution of SEL is negligible. This would pre-
vent from detecting any direct dumping event, but since no particularly 
high concentrations could be detected, this was not expected to have 
occurred in any of the WWTPs investigated during the sampling period. 
3.5.3. MDMA 
As for AMP, the two enantiomers of MDMA were detected in 
wastewater. The mean MDMA concentration (as sum of both isomers) 
Table 3 
Summary of the results obtained for the drugs measured in the various wastewater treatment plants.  
Substance Location Year Concentration(ng 
L− 1) 
Loads (mg day− 1 1000 
inhabitant− 1) 
Consumption (mg day− 1 1000 
inhabitant− 1) 
EFR 
Mean SD Mean SD Mean SD Mean SD 
AMP Bilbao and metropolitan area 2018 663 118 203 36 561 101 0.54 0.03 
2019 1375 745 277 155 766 428 0.56 0.01 
Castellón 2018 17 3 3.2 0.4 9 1 0.50 0.02 
2019 23 5 5 1 14 3 0.49 0.03 
Madrid (North) 2018 28 5 5 1 15 3 0.41 0.03 
2019 9 1 1.8 0.2 5 1 <0.45 a NC a 
Santiago de Compostela 2018 17 5 13 3 37 10 0.57 0.04 
2019 47 10 16 3 44 9 0.73 0.05 
Palma 2018 106 27 13 3 35 8 0.56 0.03 
MAMP Bilbao and metropolitan area 2018 23 14 7 5 16 11 0 0 
2019 <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL 
Castellón 2018 <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL 
2019 6 4 1.3 0.8 4 2 0 0 
Madrid (North) 2018 43 7 8 2 19 4 0 0 
2019 21 5 4 1 10 3 0 0 
Santiago de Compostela 2018 15 9 12 6 27 14 0 0 
2019 <MDL <MDL <MDL <MDL <MDL <MDL <MDL <MDL 
Palma 2018 24 15 2.9 1.9 7.1 4.6 0 0 
MDMA Bilbao and metropolitan area 2018 80 32 24 10 108 46 0.54 0.04 
2019 93 110 19 23 83 100 0.68 0.07 
Castellón 2018 12 2 2.2 0.3 8.4 2.8 0.65 0.01 
2019 41 31 9 7 39 30 0.59 0.01 
Madrid (North) 2018 78 62 18 10 80 44 0.66 0.04 
2019 36 21 7 4 33 20 0.64 0.04 
Santiago de Compostela 2018 50 21 38 14 168 60 0.57 0.03 
2019 45 24 15 8 67 35 0.64 0.03 
Palma 2018 173 104 20 11 91 51 0.55 0.02  
a R(-)-AMP was below MQL in all samples from Madrid in 2019. Thus, an average EFR but would be lower than 0.45 taking into consideration the MQL value. 
Table 4 
Comparison of AMP loads (in mg day− 1 1000 inhabitant− 1) expected from LIS 
prescription and actually found in wastewater in three of the monitored cities. 
See details on loads from prescription of LIS calculation in Table S10.  









2018 2019 2018 2019 2018 2019 
Bilbao and metropolitan area 203 277 1.52 1.03 0.75 0.37 
Madrid 5.4 NC a 3.10 4.14 58 NC a 
Palma 13 – 2.62 NC a 20 NC a 
Santiago de Compostela 13 16 4.96 7.03 37 44  
a NC: not calculated because: R(-)-AMP was below MQL in all samples from 
Madrid in 2019 and samples from Palma were only collected in 2018. 
A. Estévez-Danta et al.                                                                                                                                                                                                                         
Water Research 206 (2021) 117719
7
ranged from <MQL up to 374 ng L− 1 (Table S6). The highest concen-
trations were found in the wastewater from Palma, but once corrected 
for population and flows, this does not translate into higher loads. 
Average loads varied between 2 and 38 mg day− 1 1000 inhabitant− 1 
(Table 3), which is in the range of the already estimated MDMA loads in 
Spain in former studies (González-Mariño et al., 2020). 
The EFR average for MDMA was 0.61±0.05, being above 0.5 in all 
samples (Table S9) thus indicating the predominance of R(-)-MDMA in 
wastewater. These values match with urinary data, where 6 volunteers 
administered 100 mg of racemic MDMA leaded to an average EFR of 
0.657 over 24 h (Pizarro et al., 2002). Furthermore, an autopsy study 
revealed an EFR of 0.57 (Moore et al., 1996). As MDMA is trafficked as 
racemate (see 3.4) and the S(+)-enantiomer is metabolized faster in the 
human body, the observed enrichment of R(-)-MDMA corroborates illicit 
consumption as the main source of MDMA in wastewater (Castrignanò 
et al., 2018). No event of drug disposal in the sewage network was 
detected. 
3.5.4. Treated wastewater 
Given the high concentrations of AMP detected in the WWTP of 
Bilbao and its metropolitan area in both 2018 and 2019, treated 
wastewater samples were also collected in 2019 and in the same way as 
raw wastewater, but with a delay of 24 h to account for the hydraulic 
residence time in the plant. AMP and MAMP levels were below the MQL 
in all treated wastewater samples, whereas MDMA was detected in all 
samples. As detailed in Table S14, MDMA levels ranged from 31 to 99 ng 
L− 1 (average 57 ng L− 1), which is similar to the median value of 56 ng 
L− 1 measured in the effluents of 42 WWTPs from the region of Catalonia 
(Spain) collected during 2006 and 2007 (Huerta-Fontela et al., 2008). 
Little is known about the ecotoxicological effects of MDMA, but the 
anticipated value of predicted non-effect concentration for this sub-
stance is 220 ng L− 1 (Fernández-Rubio et al., 2019), hence emissions 
from the WWTP are not expected to generate ecotoxicological effects. 
Yet, there is a clear need for further experimental data, particularly 
considering the co-occurrence of different enantiomers (Sanganyado 
et al., 2017). 
These data imply that the removal of AMP in the WWTP, considering 
the MQL, was higher than 99%, while MDMA nominal removal was 61% 
when considering the average concentrations measured in the effluent 
and influent (MAMP was below the MQL in both types of wastewater). 
Similar good removal rates for AMP but a higher variability in the case of 
MDMA have been reported in the literature (Bijlsma et al., 2012, 2014b; 
Huerta-Fontela et al., 2008; Yadav et al., 2017). 
Furthermore, the EFR of MDMA shifted from 0.68±0.07 in the 
influent to 0.88±0.04 in the effluent, which implies a further prevalence 
of the less biologically active enantiomer, R(-)-MDMA, after the waste-
water treatment and a clear distinct elimination profile of both enan-
tiomers, i.e.: average removals of 21% and 77%, for R(-)-MDMA and S 
(+)-MDMA, respectively. Such enantioselective elimination has already 
been observed in a WWTP in Valencia studied in 2012 (Vazquez-Roig 
et al., 2014) but, as mentioned, ecotoxicological implications remain 
unknown. 
4. Conclusions 
An analytical methodology based on SPE and LC-MS/MS has been 
successfully developed for the determination of three chiral 
amphetamine-like substances in urban wastewater and street drug 
samples. The analyses of consumer-donated street drugs clearly indi-
cated that AMP and MDMA are produced as racemic mixtures for the 
Spanish illicit market, while MAMP is produced as the pure active S 
(+)-enantiomer. The enantiomeric profiling from wastewater analyses 
indicated that much higher levels of AMP occur in the metropolitan area 
of Bilbao compared to other Spanish cities, which, combined with LIS 
and SEL prescription data indicate that its origin can be attributed 
mainly to illicit consumption. Conversely, in the remaining Spanish 
cities investigated, where AMP levels are low, the prescription of LIS 
may become a relevant source of AMP, whereas the contribution of the 
prescription of the pharmaceutical SEL to AMP and MAMP loads is 
negligible. Finally, the analysis of effluent samples in the area of Bilbao 
showed that AMP is well removed in a WWTP equipped with conven-
tional biological water treatments, while the removal of MDMA is 
relatively high for the S(+)-enantiomer, but much more limited for R 
(-)-MDMA. 
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Montes, R., Pérez de Sanromán-Landa, U., Pitarch, E., Pocurull, E., Postigo, C., 
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Estévez-Danta, A., Rodil, R., Pérez-Castaño, B., Cela, R., Quintana, J.B., González- 
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Heinonen, H.E., Myllylä, V., Sotaniemi, K., Lammintausta, R., Salonen, S.J., Anttila, M., 
Savijärvi, M., Kotila, M., Rinne, K.U., 1989. Pharmacokinetics and metabolism of 
selegiline. Acta Neurol. Scand. 80 (s126), 93–99. 
Huerta-Fontela, M., Galceran, M.T., Martin-Alonso, J., Ventura, F., 2008. Occurrence of 
psychoactive stimulatory drugs in wastewaters in north-eastern Spain. Sci. Total 
Environ. 397 (1), 31–40. 
Kalant, H., 2001. The pharmacology and toxicology of "ecstasy" (MDMA) and related 
drugs. CMAJ 165 (7), 917–928. 
Kasprzyk-Hordern, B., 2010. Pharmacologically active compounds in the environment 
and their chirality. Chem. Soc. Rev. 39 (11), 4466–4503. 
Kasprzyk-Hordern, B., Baker, D.R., 2012. Enantiomeric profiling of chiral drugs in 
wastewater and receiving waters. Environ. Sci. Technol. 46 (3), 1681–1691. 
Kasprzyk-Hordern, B., Kondakal, V.V.R., Baker, D.R., 2010. Enantiomeric analysis of 
drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem 
mass spectrometry. J. Chromatogr. A 1217 (27), 4575–4586. 
King, L.A. (2009) Forensic chemistry of substance misuse: a guide to drug control. 
Krishnan, S.M., Pennick, M., Stark, J.G., 2008. Metabolism, distribution and elimination 
of lisdesxamfetamine dimesylate. Clin. Drug Investig. 28 (12), 745–755. 
Lemere, F., 1967. The danger of amphetamine dependency. Obstet. Gynecol. Surv. 22 
(3), 404–405. 
Lertxundi, U., Domingo-Echaburu, S., Orive, G., 2021. Estimation of illicit amphetamine 
consumption using wastewater based epidemiology: a tiny contribution. Sci. Total 
Environ. 779, 146349. 
Liebowitz, M.R., Karoum, F., Quitkin, F.M., Davies, S.O., Schwartz, D., Levitt, M., 
Linnoila, M., 1985. Biochemical effects of L-deprenyl in atypical depressives. Biol. 
Psychiatry 20 (5), 558–565. 
Lopardo, L., Petrie, B., Proctor, K., Youdan, J., Barden, R., Kasprzyk-Hordern, B., 2019. 
Estimation of community-wide exposure to bisphenol A via water fingerprinting. 
Environ. Int. 125, 1–8. 
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Montes, R., Rodil, R., Rico, A., Cela, R., González-Mariño, I., Hernández, F., Bijlsma, L., 
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